目錄:MedChemExpress LLC>>生化試劑>> 1400W Dihydrochloride | MCE
CAS | 214358-33-5 | 純度 | 99.94% |
---|---|---|---|
分子量 | 250.17 | 分子式 | C??H??Cl?N? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5 mg |
貨號 | HY-18731 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,,我們不為任何個人用途提供產(chǎn)品和服務(wù),。
CAS No. : 214358-33-5
產(chǎn)品活性:1400W dihydrochloride is a potent and selective inhibitor of human inducible NO synthase with Ki values of 7 nM.
研究領(lǐng)域:Immunology/Inflammation
作用靶點:NO Synthase
In Vitro: 1400W is a slow, tight binding inhibitor of human inducible nitric- oxide synthase (iNOS). The slow onset of inhibition by 1400W shows saturation kinetics with a maximal rate constant of 0.028 s-1 and a binding constant of 2.0 μM. Inhibition is dependent on the cofactor NADPH. 1400W is at least 5000-fold selective for iNOS versus eNOS. In contrast, inhibition of human neuronal NOS and endothelial NOS (eNOS) is relatively weaker, rapidly reversible, and competitive with L-arginine, with Ki values of 2 μM and 50 μM, respectively. 1400W treatment inhibits iNOS expression without affecting nNOS or eNOS. 1400W also reduces NO, 3-NT and MDA production, and prevents neuronal cell apoptosis in cerebral cortex.
In Vivo: 1400W potently (ED50=0.3 mg/kg) reduces the delayed vascular injury in rats attributable to LPS-induced iNOS but fails to exacerbate acute vascular leakage when given concurrently with LPS. Administration of 1400W lowers NOx levels in all the experimental groups. In addition, lipid peroxidation, the percentage of apoptotic cells, and nitrated protein expression fall in the late post-hypoxia period (48 h and 5 days).
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Anti-Cardiovascular Disease Compound Library | Ferroptosis Compound Library | Neuroprotective Compound Library | Angiogenesis-Related Compound Library | Targeted Diversity Library | Human Metabolite Library | Mitochondrial Protection Compound Library | Membrane Protein-targeted Compound Library | Palmitoylglycine | Ermanin | Cistanoside A | Mifepristone-13C,d3 | Dehydroevodiamine hydrochloride | Chondroitin sulfate | N'-Nitro-D-arginine | Banoxantrone | Crocin II | L-NIL hydrochloride | L-Arginine-d7 (hydrochloride) | Ethyl 3,4-dihydroxybenzoate | 2-Thiouracil-13C,15N2 | NOS-IN-3 | 3-Bromo-7-nitroindazole | Ethyl Caffeate | Beclometasone dipropionate | Carboxyebselen | (-)-10,11-Dihydroxyfarnesol | Cauloside C | Mifepristone-d3 | Atraric acid | Chloranthalactone E | Dimaprit dihydrochloride | Britannilactone diacetate | 2-Iminobiotin | Inflexuside A | TP508 | AVE3085 | Dimethoxycurcumin
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物,;
• 50,000 多種高選擇性抑制劑,、激動劑涉及各熱門信號通路及疾病領(lǐng),;
• 產(chǎn)品種類涵蓋各種重組蛋白,,多肽,常用試劑盒 ,,更有 PROTAC,、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā),、生命科學(xué)等科研項目,;
• 提供虛擬篩選,離子通道篩選,,代謝組學(xué)分析檢測分析,,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控,、驗證體系,;
• 提供 LC/MS,、NMR,、HPLC、手性分析,、元素分析等各項質(zhì)檢報告,,確保產(chǎn)品的高純度、高品質(zhì),;
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證,;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業(yè)團隊跟蹤最新的制藥及生命科學(xué)研究進展,,為您提供*新的活性化合物,;
• 與世界各大制藥公司及著名科研機構(gòu)建立了長期的合作。
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)